Published in AIDS Weekly, January 5th, 2009
"Patients with one or more primary PI mutations and HIV-1 RNA > 1000 copies/ml were randomized to receive an optimized background regimen plus darunavir/r or CPI(s). POWER 1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.